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TO THE EDITOR
Cutaneous immune responses are af-
fected by the systemic immune milieu.
Infection by Mycobacterium leprae
produces the dichotomous tuberculoid
and lepromatous forms of immune
responses in a T helper type 1 (Th1)-
dominant and a Th2-dominant milieu,
respectively (Yamamura et al., 1991). In
animal models, cutaneous Leishmania
major infection is resistant by Th1-
dominant C57BL/6 mice but is suscep-
tible in Th2-dominant BALB/c mice
(Lopez-Kostka et al., 2009). Interest-
ingly, atopic dermatitis (AD), a chronic
inflammatory skin disease, also mani-
fests in various degrees of clinical
severity (Jones et al., 1975; Bonness
and Bieber, 2007; Hanifin, 2009). We
have previously generated a mouse
model of AD by overexpression of a
Th2 cytokine IL-4 in the basal epidermis
of transgenic (Tg) mice (Chan et al.,
2001). Using this model, we documen-
ted that the disease onset occurs in
parallel with a surge of cutaneous Th2
cytokines (Chen et al., 2004). However,
the extent to which a Th2-dominant
systemic immune milieu influences the
cutaneous inflammation is unknown.
Therefore, this study was conducted to
answer this question.
We crossed and backcrossed the
original IL-4-Tg mice of the outbred
CByB6 strain into purebred Th1-
dominant C57BL/6 and Th2-dominant
BALB/c strains (Harlan, Indianapolis,
IN), generating IL-4-Tg C57BL/6-Tg
(C-Tg) and IL-4-Tg BALB/c-Tg (B-Tg)
strains. All generations of these mice
were housed in special pathogen-free
cages and fed regular mouse chow and
standard water. Owing to heavy disease
burden and inability to breed further,
only three generations were obtained in
the BALB/c strain. Therefore, seventh-
generation C-Tg and third-generation
B-Tg mice were studied (as approved
by the University of Illinois at Chicago
Animal Care Committee). Mice were
killed 3 weeks after dermatitis onset,
and sera and skin lesions were col-
lected. For nontransgenic (NT) litter-
mate controls, sera and normal ear
tissues were collected from age-mat-
ched C57BL/6-NT (C-NT) and BALB/c-
NT (B-NT) offspring. We compared the
clinical phenotypes of these Tg strains,
including age of onset and percentage
of skin affected. We determined relative
skin cytokine mRNA quantities by real-
time PCR following reverse transcrip-
tion of skin-extracted RNA (Chen et al.,
2004), total sera IgE, and IgG1 (by
sandwich ELISA) (Chen et al., 2005b),
and skin inflammatory cells/vascular
markers/adhesion molecules were qua-
ntified by immunofluorescence micro-
scopy (Chen et al., 2005a). Statistical
analyses were performed using Graph-
Pad Instat Software (GraphPad, San
Diego, CA). The difference between
medians of two groups was determined
by the Mann–Whitney test. Experimen-
tal data were processed as means
±SEM. A P-value of p0.05 was con-
sidered significant.
As expected, skin lesions character-
istic of AD were observed in all C-Tg
(n¼12) and B-Tg (n¼ 11) mice, but in
none of the NT mice (Figure 1a and b)
(Chen et al., 2004). Skin lesions
were clinically similar, with erythema,
scaling, and crusting (Figure 1a).
Histopathologically, hematoxylin and
eosin staining showed similar morpho-
logy of acanthosis, hyperkeratosis,
parakeratosis, spongiosis, and promi-
nent inflammatory infiltrates in both Tg
strains (Figure 1b). Both Tg mouse
strains developed skin inflammation
notwithstanding that significantly more
body surface area was affected in the
B-Tg mice than in the C-Tg mice
(Po0.001, Figure 1a and c), and
the B-Tg mice developed dermatitis
much earlier than did C-Tg mice
(Po0.0001, Figure 1d). These data
support a notion that a Th2-dominant
background enhances the clinical
features of AD.
We next examined whether total
serum IgE levels affect skin inflamma-
tion. Although C-Tg mice had a statis-
tically significant higher IgE level
than did C-NT mice, B-Tg mice did
not increase their IgE levels relative to
B-NT mice, whose baseline IgE levels
were higher than those in C-NT mice
(Figure 1e). The IgG1 level in B-NT
mice (average 3.48 ngml1) was also
significantly higher than that in C-NT
mice (average 1.33 ngml1, Po0.05).
Although the absence of IgE upregula-
tion is known in the intrinsic subset
of AD (Novak and Bieber, 2003) and
in the SKH1-IL-4-Tg AD model (Chen
et al., 2008b), the mechanism
of IgE regulation in B-Tg mice remains
unclear.
We then asked whether cytokine
levels in skin lesions of Th2-dominant
B-Tg mice (earlier onset with higher
percentage of skin affected) differ
from those of Th1-dominant C-Tg mice
(later onset with smaller percentage of
skin affected). Significantly greater
numbers of mRNA copies of Th2
cytokines (IL-4, IL-10, IL-13), proin-
flammatory cytokine IL-1b, and Th1
cytokine IL-2 were found in the lesional
skin of B-Tg mice than in that of C-Tg
mice (Po0.05, Figure 1f). IL-6, INF-g,
and tumor necrosis factor-b levels were
higher in B-Tg mice than in C-Tg mice,
Abbreviations: AD, atopic dermatitis; B-Tg, BALB/c-transgenic; C-NT, C57BL/6-nontransgenic;
C-Tg, C57BL/6-transgenic; NT, nontransgenic; Tg, transgenic
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Figure 1. B-Tg mice developed skin lesions earlier and more extensively and exhibited higher levels of Th2 cytokines and other pro-inflammatory cytokines
than did C-Tg mice. (a) B-Tg mice (top right) had more lesions compared with C-Tg mice (top left), whereas no lesions were seen in in C-NT mice (bottom left)
and B-NT mice (right bottom). (b) Both C-Tg (top left) and B-Tg (top right) skin lesions showed acanthosis, hyperkeratosis, parakeratosis, spongiosis, and
inflammatory infiltrates compared with the corresponding NT histology (C-NT bottom left; B-NT bottom right). H&E,  40. Bar¼ 70 mm. (c) B-Tg mice had
significantly more body surface area affected (17.7±1.8%) than did C-Tg mice (5.8±1.3%), *Po0.001. (d) In B-Tg mice inflammation onset occurred at a
significantly younger age (11.0±2.0 days) than in C-Tg mice (89.1±4.6 days), *Po0.0001. (e) Total serum IgE significantly increased in C-Tg (1,574.6±269.37)
versus C-NT (567.58±57.20) mice, *Po0.05. (f) B-Tg mice had higher levels of nearly all cytokines than did C-Tg mice. *Po0.05. B-NT, BALB/c-
nontransgenic; B-Tg, BALB/c-transgenic; C-NT, C57BL/6-nontransgenic; C-Tg, C57BL/6-transgenic; H&E, hematoxylin and eosin.
Figure 2. B-Tg and C-Tg mice exhibited similar infiltrating T cells, vasculature, and vascular adhesion molecules. (a) Immunofluorescence microscopy with primary
antibodies and Alexa fluor 488-conjugated secondary antibodies. Bar¼70mm. (b, c) Dermal numbers per high-power field (HPF) for C-NT, C-Tg, B-NT, and B-Tg mice
are CD3þ (7.19±0.91, 42.01±6.74, 5.67±0.52, 31.27±3.05, respectively), CD4þ (5.69±0.53, 26.86±3.80, 3.42±0.37, 19.42±2.23), CD8þ (0.89±0.24,
7.22±1.22, 0.67±0.14, 4.83±0.80), PECAMþ (7.67±0.36, 24.36±1.76, 9.21±0.53, 26.07±2.82), P-selectinþ (0.24±0.09, 8.20±1.02, 0.49±0.20,
7.44±0.86), and VCAMþ (0.54±0.14, 3.26±0.57, 0.31±0.12, 1.72±0.19). Significant as compared with the NT strain: #Po0.05, *Po0.01, **Po0.001. Significant
comparison between C-Tg and B-Tg strains: zPo0.05. B-NT, BALB/c-nontransgenic; B-Tg, BALB/c-transgenic; C-NT, C57BL/6-nontransgenic; C-Tg, C57BL/6-transgenic.
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although not significantly. Our data are
consistent with findings in another Tg
murine AD model that higher levels of
Th2 cytokines correlated with earlier
development and increased severity of
AD (Lee and Flavell, 2004).
We further investigated whether en-
hanced skin inflammation in B-Tg mice
can be explained by variations in
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lesional inflammatory cell infiltration,
vascular adhesion molecules, or angio-
genesis (Figure 2). When comparing
C-Tg with C-NT mice, we found sig-
nificantly more CD3þ cells, CD4þ
cells, and CD8þ cells in the Tg strain’s
dermis (all with Po0.001). Similarly,
the B-Tg dermis had significantly more
CD3þ cells (Po0.01), CD4þ cells
(Po0.01), and CD8þ cells (Po0.05)
compared with its B-NT counterpart.
Both C-Tg and B-Tg mice had signifi-
cantly more PECAMþ vessels per high-
power field compared with their NT
littermates (Po0.001), further support-
ing a role of angiogenesis in AD (Chen
et al., 2008a). Similarly, C-Tg and
B-Tg mice had more P-selectinþ and
VCAMþ vessels than did their NT
littermates (Po0.001); this was identi-
cal to the previous findings in AD
patients and in an AD model (Sigurds-
son et al., 2000; Chen et al., 2010).
There was no difference in numbers
of CD3þ and CD4þ lymphocytes,
PECAMþ , and P-selectinþ vessels
between the dermis of the two Tg
strains. The physiological implications
of more CD8þ cells and VCAMþ
vessels per high-power field in the
dermis but with less skin inflammation
in C-Tg mice, as compared with B-Tg
mice, are unclear (Figure 2b and c).
The Th2 systemic immune milieu
strongly enhances the rate and extent
of cutaneous inflammation in our
AD model by primarily increasing the
expression of cutaneous Th2 cytokines
and other proinflammatory cytokine.
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TO THE EDITOR
IL-33, a novel member of the IL-1
family, was recently identified as a
ligand for the orphan receptor ST2
(Schmitz et al., 2005). ST2 is selectively
and stably expressed on the cell surface
of T-helper 2 (Th2) cells, but not Th1
cells (Xu et al., 1998). IL-33–ST2 inter-
actions exacerbate Th2- and mast
cell-mediated inflammatory diseases
(Pre´fontaine et al., 2009). The soluble
form of ST2 functions as a decoyAbbreviations: AD, atopic dermatitis; Th, T helper
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